Evidence map›Paper›PMID 42040556›Full record

ArticleFrontiers in medicine2026

CO

Mingyue Luo, Ying Chen, Lu Sun, Youxin Chen, Meifen Zhang, Huan Chen, Rongping Dai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mingyue LuoDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Ying ChenXi'an People's Hospital (Xi'an Fourth Hospital), Shannxi Eye Hospital, Xi'an, Shannxi, China.
Lu SunDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Youxin ChenDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Meifen ZhangDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Huan ChenDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Rongping DaiDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Surgical treatment of idiopathic uveal effusion syndrome (UES) is challenging with high risks. CO Methods: This was a prospective descriptive case series. After fully exposed, the sclera was ablated with CO Results: The technique was used in three eyes of three patients with UES and exudative retinal detachment (RD). After a mean follow-up of 410 days (range, 34-825 days), all patients demonstrated sustained improvement of RD, with complete resolution in two cases. No adverse events were observed during the extended follow-up period. Conclusion: CLASS with sclerostomy appears to be a feasible and durable technique for UES in this small series, though further studies are warranted.

Indexed as

choroidal effusionCO2 laser-assisted sclerectomysclerectomysurgeryuveal effusion syndrome

Identifiers

PMID42040556
PMCPMC13105963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.